| Authors |
n |
IPC used |
Mean PCI |
Mean No. of Liver Lesions |
Median follow-up(months) |
Median over all survival (months) |
Median disease-frees urvival (months) |
Survival rates (%) |
Morbidity
n(%)* |
Mortality
n(%)* |
| Alzahranietal.
(current study-unpublished data) |
78 |
HIPEC: Oxaliplatin 350mg/m2 500mL of 5% dextrose,42°C,30 minutes.
Mitomycin (12.5mg/m2),42ºC, 3L,30-90 minutes.EPIC:1L650-800 mg/m25-FUin1L1-5 days (pre02/10). |
12.7 |
2.7 |
21.8 |
32.8 |
13.5 |
A:1,3,5 year: 95,62 and 31
B:1,3,5 year: 74,33 and 18 |
27(34.6) |
1(1.3) |
| Ungetal. |
36 |
HIPEC: Mitomycin (12.5mg/m2)in 42ºC 3L peritoneal dialysis fluid,30-90 minutes.
EPIC:1L650-800 mg/m2 5-FUin1L peritoneal dialysis fluid,1-5days |
7.0 |
2.3 |
21.8 |
24.4 |
8.5 |
1,3,5 year: 74, 33 and 18 |
14(39) |
1(3) |
| Maggiori etal. [22] |
37 |
— |
11 (median) |
2 (median) |
36 (mean) |
32 |
9 |
3 and 5 year:40 and 26 |
19(51) |
3(8) |
| Chua etal. [23]** |
16(55 total) |
AsUngetal. |
8.0 |
— |
19 |
— |
— |
2year:65% |
17(31)* |
0 |
| Kianmanesh etal.[24]*** |
16(43 total) |
HIPEC:6 Lmitomycin 120 mg and 6L 200mg/m2 for 30-90minutes |
— |
— |
— |
36 |
— |
— |
17(39)* |
1(2)* |
| Elias etal.[25] |
24 |
Various |
8.6 |
4.4 |
27.8 (mean) |
30-36 |
18-24 |
2,3,5 year:61.3,41.5 and 26.5 |
14(58) |
1(4) |
| MEDIAN (RANGE) [26] |
8.6(7-12.7) |
2.5(2-4.4) |
21.8(19-36) |
24.4-36 |
8.5-24 |
5-year: 26.25 (18-31) |
35(31-58) |
1(0-8) |
|